Alignment Healthcare (ALHC) CMO sells 18,404 shares to cover taxes

Rhea-AI Filing Summary

Alignment Healthcare, Inc. Chief Medical Officer Hyong Kim reported an open-market sale of 18,404 shares of common stock at a weighted-average price of $17.84 per share. According to the filing, these shares were sold solely to cover tax withholding obligations from vesting restricted stock units and did not represent a discretionary trade.

After this transaction, Kim directly holds 367,701 shares of Alignment Healthcare common stock. The shares were sold in multiple trades at prices ranging from $17.40 to $18.24 per share.

Insider Trade Summary

Net Seller: 18,404 shares ($328,327)

Net Sell 1 txn

Insider Kim Hyong

Role Chief Medical Officer

Sold 18,404 shs ($328K)

Type	Security	Shares	Price	Value
Sale	Common Stock	18,404	$17.84	$328K

Holdings After Transaction: Common Stock — 367,701 shares (Direct)

Footnotes (1)

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kim Hyong

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		S		18,404(1)	D	$17.84(2)	367,701	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Hyong (Ken) Kim	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Alignment Healthcare (ALHC) report for Hyong Kim?

Alignment Healthcare’s Chief Medical Officer Hyong Kim reported selling 18,404 common shares. The filing explains the sale was made to satisfy tax withholding obligations arising from the vesting of restricted stock units, rather than as a discretionary decision to reduce his holdings.

How many Alignment Healthcare (ALHC) shares did Hyong Kim sell and at what price?

Hyong Kim sold 18,404 Alignment Healthcare common shares at a weighted-average price of $17.84. The sale occurred through multiple trades, with individual transaction prices ranging from $17.40 to $18.24 per share as disclosed in the Form 4 footnotes.

Why were Hyong Kim’s Alignment Healthcare (ALHC) shares sold in this Form 4?

The shares were sold to cover tax withholding obligations triggered by vesting restricted stock units. The Form 4 explicitly states this transaction does not represent a discretionary trade by Hyong Kim, indicating it was a mechanical tax-related sale rather than an active portfolio decision.

How many Alignment Healthcare (ALHC) shares does Hyong Kim hold after the sale?

Following the reported transaction, Hyong Kim directly holds 367,701 shares of Alignment Healthcare common stock. This post-transaction balance, shown in the Form 4, provides context that the 18,404 shares sold represent a small fraction of his overall direct ownership position.

Was Hyong Kim’s Alignment Healthcare (ALHC) stock sale a discretionary trade?

No. The Form 4 footnote clarifies that the 18,404 shares sold were required to cover tax withholding obligations related to restricted stock unit vesting. It specifically notes the transaction does not represent a discretionary trade by the reporting person, limiting its signaling value.

Over what price range were Hyong Kim’s Alignment Healthcare (ALHC) shares sold?

The filing reports that shares were sold at prices ranging from $17.40 to $18.24 per share. The weighted-average sale price disclosed is $17.84, and the footnote offers to provide complete breakdowns of the number of shares sold at each individual price upon request.